Dr.Antonio Prinzi – Endocrine Oncology – Best Researcher Award

Dr.Antonio Prinzi - Endocrine Oncology - Best Researcher Award

University of Catania - Italy

AUTHOR PROFILE

ORCID

EARLY ACADEMIC PURSUITS:

Antonio Prinzi, MD, began his academic journey at the University of Palermo, earning his Degree in Medicine and Surgery in July 2020 with the exceptional grade of 110/110 cum laude. His early academic pursuits laid the foundation for his subsequent achievements and contributions in the field of endocrinology and metabolism.

PROFESSIONAL ENDEAVORS:

Following his medical degree, Dr. Prinzi registered with the Order of Doctors of Palermo in August 2020. He then undertook a Post-graduate Fellowship in Endocrinology and Metabolism Diseases at the University of Catania, a nationally renowned specialist Medical Center (ARNAS) Garibaldi, starting in January 2021 and continuing to the present. Additionally, he gained valuable international experience during his Fellowship and research at Erasmus MC: University Medical Center in Rotterdam from December 2022 to June 2023.

CONTRIBUTIONS AND RESEARCH FOCUS ON ENDOCRINE ONCOLOGY

Dr. Prinzi's research focus is evident in his scientific publications. Notably, he contributed to a study on circulating Irisin levels as a marker of osteosarcopenic-obesity in Cushing's disease, published in Diabetes Metab Syndr Obes in May 2020. Another publication in Endocr Pract in November 2023 explores the lymph node ratio as a predictive factor of persistent/recurrent disease in patients with medullary thyroid cancer.

IMPACT AND INFLUENCE:

His impact is evident in his role as a Post-graduate Fellow at the University of Catania, where he actively contributes to the field of endocrine oncology. The international experience gained in Rotterdam further enhances his influence on a global scale, fostering collaboration and knowledge exchange.

ACADEMIC CITES:

Dr. Prinzi's work has been cited in reputable journals, showcasing the recognition and relevance of his research contributions. The citations demonstrate the impact of his studies on the scientific community.

LEGACY:

As a young and accomplished medical professional, Dr. Prinzi is building a legacy marked by academic excellence, research contributions, and a commitment to advancing endocrinological knowledge. His early accomplishments and international experiences contribute to the foundation of his lasting legacy in the medical field.

FUTURE CONTRIBUTIONS:

Looking forward, Dr. Prinzi's future contributions are anticipated to further enrich the field of endocrinology. His dedication to research, international exposure, and clinical expertise position him for continued impact in understanding and treating endocrine and metabolic diseases.

Notable Publication

Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study.2023

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease. 2020

 

 

 

 

Aya H. Soliman – Tumor Immunology – Best Researcher Award

Ms.Aya H. Soliman - Tumor Immunology - Best Researcher Award

German University in Cairo - Egypt

AUTHOR PROFILE

Scopus

Orcid 

EARLY ACADEMIC PURSUITS:

Aya H. Soliman's academic journey commenced with a fervent pursuit of knowledge. Her early years were marked by a dedication to learning, demonstrating an insatiable curiosity and a penchant for academic excellence. Whether it be notable achievements, academic milestones, or early influences, this period laid the foundation for her future endeavors.

PROFESSIONAL ENDEAVORS:

Embarking on a path of professional growth, Soliman transitioned seamlessly from academia to the professional realm. Her career trajectory reflects a commitment to applying theoretical knowledge to real-world challenges. A closer examination of her professional undertakings unveils a strategic and purposeful approach to making significant contributions in her chosen field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Soliman's contributions to her field are nothing short of groundbreaking. Her research focus is characterized by a meticulous exploration of pertinent issues, coupled with innovative methodologies. By delving into specific themes, she has enriched the academic landscape with fresh perspectives and novel insights, leaving an indelible mark on her area of expertise.

IMPACT AND INFLUENCE:

The impact of Soliman's work extends far beyond the confines of academia. Her research and professional activities have influenced not only fellow scholars but also practitioners in the field. By contributing to the advancement of knowledge, she has played a pivotal role in shaping industry practices and policies, showcasing a far-reaching influence.

ACADEMIC CITES:

A quantitative measure of Soliman's academic influence lies in the citation of her work. The number of times her research has been referenced underscores its significance within scholarly discourse. Her contributions have become integral to the academic canon, with citations serving as a testament to the enduring relevance of her ideas.

FUTURE CONTRIBUTIONS:

Looking ahead, Soliman's future contributions hold promise for continued innovation and advancement. Anticipating the evolving landscape of her field, she remains poised to address emerging challenges and contribute novel solutions. The trajectory of her future contributions is eagerly awaited, promising to shape the direction of academic and professional discourse.

Notable Publications

Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis. 2023

 

 

Maria A. Perez Herrero – Perioperative Management in Oncological Surgery – Best Researcher Award

Dr. Maria A. Perez Herrero's - Perioperative management in oncological surgery - Best Researcher Award

Hospital Clinico Universitario de Valladolid - Spain

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Maria A. Perez Herrero commenced her academic journey with a notable achievement, obtaining her Licenciatura en Medicina y CirugĂ­a from the Faculty of Medicine, Valladolid, with a Grado de licenciatura: SOBRESALIENTE in June 1991. This early success set the foundation for her subsequent academic and professional endeavors.

PROFESSIONAL ENDEAVORS:

Dr. Perez Herrero's commitment to medical excellence is evident in her pursuit of specialized training. Following her initial academic success, she engaged in Cursos monográficos de Doctorado en Farmacología from September 1994 to June 1996. Her dedication culminated in the completion of her Tesis Doctoral, "Alergias en la Práctica Clínica Anestesiológica," earning her the distinction of APTO CUM LAUDE in September 1997.

CONTRIBUTIONS AND RESEARCH FOCUS ON PERIOPERATIVE MANAGEMENT IN ONCOLOGICAL SURGERY

Dr. Perez Herrero made significant contributions to her field, as demonstrated by her Lectura de la Tesis Doctoral and subsequent roles as MĂ©dico Especialista en AnestesiologĂ­a y ReanimaciĂłn. Her engagement in Guardias en el Servicio de Urgencias and Guardias en los Servicios de Anestesia y ReanimaciĂłn reflects her dedication to both emergency care and specialized anesthesia services.

IMPACT AND INFLUENCE:

Dr. Perez Herrero's impact extends beyond clinical settings. Her involvement as Profesor Colaborador HonorĂ­fico and collaborations with various departments at the Universidad de Valladolid showcase her influence in academia. Additionally, her contributions to the Real Academia de Medicina y CirugĂ­a de Valladolid underscore her standing in the medical community.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Maria A. Perez Herrero's legacy is marked by a rich tapestry of academic achievements, professional roles, and contributions to medical education. As a Profesor Colaborador HonorĂ­fico, her influence continues, shaping the education and training of future medical professionals. Her commitment to academia and clinical excellence positions her as a role model for aspiring healthcare practitioners.

NOTABLE PUBLICATIONS

Quality of postoperative recovery after breast surgery. General anaesthesia combined with paravertebral versus serratus-intercostal block.2016